Sp1 transactivation of the TCL1 oncogene

被引:25
作者
French, SW
Malone, CS
Shen, RR
Renard, M
Henson, SE
Miner, MD
Wall, R
Teitell, MA
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, MacDonald Res Labs 4 760,Ctr Hlth Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Hlth Sci Ctr, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Hlth Sci Ctr, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Hlth Sci Ctr, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Hlth Sci Ctr, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Hlth Sci Ctr, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.M207166200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cis-regions and trans-factors controlling TCL1 oncogene expression are not known. We identified the functional TCL1 promoter by mapping four transcriptional start sites 24-30 bp downstream of a TATA box. A 424-bp fragment upstream of the major start site showed robust promoter activity comparable with SV40 in both TCL1 expressing and non-expressing cell lines. Additional constructs spanning 10 kb upstream and 20 kb downstream of the start site showed only modest increases in reporter activity indicating that TCL1 expression is primarily controlled by the promoter. Ten putative Sp1-binding sites were identified within 300 bp of the start site, and three of these specifically bound Sp1. A dose-dependent transactivation of the TCL1 promoter with Sp1 addition in Sp1-negative Drosophila SL2 cells was observed, and mutation of the three identified Sp1-binding sites significantly repressed reporter gene expression in 293T cells, confirming a key role for Sp1 in activating the TCL1 promoter in vivo. In TCL1 silent cell lines, CpG DNA methylation was rarely observed at functional Sp1 sites, and methylation of a previously reported NotI restriction site was associated with dense CpG methylation rather than endogenous TCL1 gene silencing. Together, these results indicate that Sp1 mediates transactivation of the TCL1 core promoter and that TCL1 gene silencing is not dependent on mechanisms involving Sp1 and Not1 site methylation.
引用
收藏
页码:948 / 955
页数:8
相关论文
共 73 条
[1]  
Arvand A, 2001, CANCER RES, V61, P5311
[2]   CYTOSINE METHYLATION IN CTF AND SP1 RECOGNITION SITES OF AN HSV TK PROMOTER - EFFECTS ON TRANSCRIPTION INVIVO AND ON FACTOR BINDING INVITRO [J].
BENHATTAR, J ;
BEARD, P ;
JIRICNY, J .
NUCLEIC ACIDS RESEARCH, 1989, 17 (24) :10179-10190
[4]   Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression [J].
Bichi, R ;
Shinton, SA ;
Martin, ES ;
Koval, A ;
Calin, GA ;
Cesari, R ;
Russo, G ;
Hardy, RR ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6955-6960
[5]   Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3 [J].
Birnbaum, MJ ;
vanWijnen, AJ ;
Odgren, PR ;
Last, TJ ;
Suske, G ;
Stein, GS ;
Stein, JL .
BIOCHEMISTRY, 1995, 34 (50) :16503-16508
[6]   SP1 ELEMENTS PROTECT A CPG ISLAND FROM DE-NOVO METHYLATION [J].
BRANDEIS, M ;
FRANK, D ;
KESHET, I ;
SIEGFRIED, Z ;
MENDELSOHN, M ;
NEMES, A ;
TEMPER, V ;
RAZIN, A ;
CEDAR, H .
NATURE, 1994, 371 (6496) :435-438
[7]  
BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
[8]   BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS [J].
CATTORETTI, G ;
CHANG, CC ;
CECHOVA, K ;
ZHANG, JD ;
YE, BH ;
FALINI, B ;
LOUIE, DC ;
OFFIT, K ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1995, 86 (01) :45-53
[9]  
CHEN JH, 1993, ONCOGENE, V8, P133
[10]   Sp1 binding is inhibited by (m)Cp(m)CpG methylation [J].
Clark, SJ ;
Harrison, J ;
Molloy, PL .
GENE, 1997, 195 (01) :67-71